ATE455786T1 - 6-11 bicyclische ketolidderivate - Google Patents

6-11 bicyclische ketolidderivate

Info

Publication number
ATE455786T1
ATE455786T1 AT03733983T AT03733983T ATE455786T1 AT E455786 T1 ATE455786 T1 AT E455786T1 AT 03733983 T AT03733983 T AT 03733983T AT 03733983 T AT03733983 T AT 03733983T AT E455786 T1 ATE455786 T1 AT E455786T1
Authority
AT
Austria
Prior art keywords
present
compounds
subject
ketolide derivatives
invention further
Prior art date
Application number
AT03733983T
Other languages
English (en)
Inventor
Yat OR
Guoqiang Wang
Ly Phan
Deqiang Niu
Nha Huu Vo
Yao-Ling Qiu
Yanchun Wang
Marina Busuyek
Ying Hou
Yulin Peng
Heejin Kim
Tongzhu Liu
Jay Judson Farmer
Guoyou Xu
Original Assignee
Enanta Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enanta Pharm Inc filed Critical Enanta Pharm Inc
Priority claimed from PCT/US2003/014669 external-priority patent/WO2003097659A1/en
Application granted granted Critical
Publication of ATE455786T1 publication Critical patent/ATE455786T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
AT03733983T 2002-05-13 2003-05-09 6-11 bicyclische ketolidderivate ATE455786T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14455802A 2002-05-13 2002-05-13
US10/429,485 US6878691B2 (en) 2002-05-13 2003-05-05 6-11 bicyclic ketolide derivatives
PCT/US2003/014669 WO2003097659A1 (en) 2002-05-13 2003-05-09 6-11 bicyclic ketolide derivatives

Publications (1)

Publication Number Publication Date
ATE455786T1 true ATE455786T1 (de) 2010-02-15

Family

ID=34134634

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03733983T ATE455786T1 (de) 2002-05-13 2003-05-09 6-11 bicyclische ketolidderivate

Country Status (10)

Country Link
US (1) US6878691B2 (de)
KR (1) KR100687956B1 (de)
CN (1) CN102127133B (de)
AT (1) ATE455786T1 (de)
CY (1) CY1109970T1 (de)
DE (1) DE60331056D1 (de)
DK (1) DK1506214T3 (de)
ES (1) ES2339647T3 (de)
PT (1) PT1506214E (de)
TW (1) TWI327573B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7135573B2 (en) * 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US6841664B2 (en) * 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
EP1509538A1 (de) * 2002-05-13 2005-03-02 Enanta Pharmaceuticals, Inc. 6,11 bizyklische erythromycinderivate
AR043050A1 (es) * 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
BRPI0408117A (pt) * 2003-03-05 2006-03-01 Rib X Pharmaceuticals Inc compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
EP1670808A1 (de) * 2003-09-12 2006-06-21 Chiron Corporation Antimikrobielle derivate
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
JP2007512256A (ja) * 2003-11-18 2007-05-17 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 二官能性マクロライド複素環化合物ならびにこれらを製造する方法およびこれらを使用する方法
WO2005067564A2 (en) * 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
US7265094B2 (en) * 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
EP2716647A3 (de) * 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Makrocyclische Verbindungen Und Verfahren Zu Deren Herstellung Und Anwendung
US20060058247A1 (en) * 2004-09-16 2006-03-16 Yujiro Hata Methods and compositions for treating cystic fibrosis
US7538225B2 (en) * 2005-05-02 2009-05-26 Enanta Pharmaceuticals, Inc. Processes for the preparation of o-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
BRPI0610477A2 (pt) * 2005-05-04 2010-06-22 Enanta Pharm Inc composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma infecção bacteriana, de uma inflamação e de fibrose cìstica em um paciente com necessidade do mesmo
US20060252710A1 (en) * 2005-05-04 2006-11-09 Guoqiang Wang 6-11 Bridged oxime erythromycin derivatives
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
US7589067B2 (en) * 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
EP1960413A2 (de) * 2005-11-23 2008-08-27 Ranbaxy Laboratories Limited Makrolidderivate als antibakterielle mittel
US7563877B2 (en) * 2006-03-02 2009-07-21 Enanta Pharmaceuticals, Inc. Processes for the preparation of 0-(2-aminobenzo[d]oxazol-5-yl)methyl hydroxylamine for the synthesis of 6,11-bicyclic erythromycin derivative EDP-182
US20070231368A1 (en) * 2006-03-30 2007-10-04 Enanta Pharmaceuticals, Inc. Pharmaceutical formulations of 6-11 bicyclic macrolide derivative known as edp-182 and methods for preparation thereof
EP2023721A2 (de) * 2006-06-05 2009-02-18 Auspex Pharmaceuticals Inc. Herstellung und verwendung substituierter erythromycin-analoge
US20080027012A1 (en) * 2006-07-24 2008-01-31 Heejin Kim Bridged carbamate macrolides
US20080039406A1 (en) * 2006-08-04 2008-02-14 Yao-Ling Qiu 3,6-bridged tylosin derivatives
US7622452B2 (en) * 2006-11-16 2009-11-24 Enanta Pharmaceuticals, Inc. C-9 alkenylidine bridged macrolides
US7524512B2 (en) * 2007-07-13 2009-04-28 Di Bartolomeo Joseph R Composition and method for the prevention and relief of the symptoms of an incompetent or patulous Eustachian tube
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
KR101223158B1 (ko) * 2007-09-17 2013-01-17 이난타 파마슈티칼스, 인코포레이티드 6,11-다리걸친 바이아릴 매크로라이드
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
US20090131343A1 (en) * 2007-11-15 2009-05-21 Ly Tam Phan Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
US7842813B2 (en) * 2008-05-09 2010-11-30 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamine
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
WO2009137787A1 (en) 2008-05-09 2009-11-12 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
KR101118597B1 (ko) * 2008-12-24 2012-02-27 한국전자통신연구원 모바일용 컴퓨터 그래픽 랜더링 방법 및 시스템
US8796474B1 (en) 2010-08-23 2014-08-05 Rutgers, The State University Of New Jersey Macrolide compounds and methods and intermediates useful for their preparation
EP2794824B1 (de) * 2011-12-19 2018-10-31 Biosynthetic Technologies, LLC Verfahren zur herstellung von estolidgrundölen und oligomere verbindungen mit kreuzmetathese

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960000434B1 (ko) 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
US4921836A (en) 1989-05-17 1990-05-01 Burroughs Wellcome Co. Substituted glutamic acids
IL99995A (en) 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
DE69127457T2 (de) 1990-11-28 1998-01-22 Taisho Pharmaceutical Co., Ltd., Tokio/Tokyo 6-0-methylerythromycin a-derivat
US5202434A (en) 1991-04-05 1993-04-13 Merck & Co., Inc. 8a-aza-8a-homoerythromycin lactams
US5556839A (en) 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
US5631355A (en) 1992-04-22 1997-05-20 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide a derivatives
US5527780A (en) 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
US5441939A (en) 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
FR2738571B1 (fr) 1995-09-11 1997-10-17 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US6124269A (en) 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
US6046171A (en) 1997-10-29 2000-04-04 Abbott Laboratories 6,11-bridged erythromycin derivatives
IL145976A0 (en) 1999-04-16 2002-07-25 Ortho Mcneil Pharm Inc Ketolide antibacterials

Also Published As

Publication number Publication date
TW200400969A (en) 2004-01-16
CN102127133B (zh) 2015-04-15
KR20050003455A (ko) 2005-01-10
KR100687956B1 (ko) 2007-02-28
PT1506214E (pt) 2010-04-27
DE60331056D1 (de) 2010-03-11
CY1109970T1 (el) 2014-09-10
DK1506214T3 (da) 2010-05-25
CN102127133A (zh) 2011-07-20
US6878691B2 (en) 2005-04-12
HK1074447A1 (en) 2005-11-11
TWI327573B (en) 2010-07-21
ES2339647T3 (es) 2010-05-24
US20050037982A1 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
DK1506214T3 (da) 6-11 bicykliske ketolidderivater
WO2004062601A3 (en) Antibacterial agents
WO2005000863A3 (en) 6, 11-4c-bicyclic 9a-azalide derivatives
UA94901C2 (ru) Антибактериальные производные пиперидина
WO2004087728A3 (en) 6,11-3c-bicyclic 9a-azalide derivatives
WO2008154642A3 (en) Antibacterial agents
NO20092542L (no) Antibakterielle kinolin-derivater
WO2004096823A3 (en) Novel ketolide derivatives
BR0310050A (pt) Derivados de cetolida 6-11 bicìclicas, composições farmacêuticas e processos referentes aos mesmos
NO20092539L (no) Antibakterielle kinolin-derivater
EA200802058A1 (ru) Производные циклоалкиламинокислот и их фармацевтические композиции
CA2483875A1 (en) 6,11 bicyclic erythromycin derivatives
MX2010002932A (es) Macrolidos de biarilo con puente en 6, 11.
TW200634021A (en) 3,6-bicyclolides
WO2005070113A3 (en) 9n-substituted 6-11 bicyclic erythromycin derivatives
NO20092547L (no) Antibakterielle kinolin-derivater
WO2006039263A3 (en) NOVEL BICYCLIC 9a-AZALIDE DERIVATIVES
WO2005067564A3 (en) 6-11 bicyclic erythromycin derivatives
WO2006065721A3 (en) 11, 12-lactone bicyclolides
NO20092536L (no) Antibakterielle kinolin-derivater
NO20092540L (no) Antibakterielle kinolin-derivater
TW200635600A (en) Tetracyclic bicyclolides
NO20092541L (no) Antibakterielle kinolin-derivater
WO2007044927A3 (en) 6, 11-bridged tricyclic macrolides
WO2008014221A3 (en) Bridged carbamate macrolides

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1506214

Country of ref document: EP